The Manufacturers Life Insurance Company lifted its holdings in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 1.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,819,058 shares of the company’s stock after acquiring an additional 20,467 shares during the period. The Manufacturers Life Insurance Company owned 0.32% of Express Scripts worth $125,659,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. SeaCrest Wealth Management LLC purchased a new position in shares of Express Scripts during the fourth quarter worth approximately $105,000. Wealthcare Advisory Partners LLC grew its position in shares of Express Scripts by 364.7% during the first quarter. Wealthcare Advisory Partners LLC now owns 1,529 shares of the company’s stock worth $106,000 after acquiring an additional 1,200 shares during the last quarter. Aevitas Wealth Management Inc. purchased a new position in shares of Express Scripts during the fourth quarter worth approximately $128,000. Financial Gravity Companies Inc. purchased a new position in shares of Express Scripts during the fourth quarter worth approximately $142,000. Finally, Archford Capital Strategies LLC purchased a new position in shares of Express Scripts during the first quarter worth approximately $157,000. Institutional investors and hedge funds own 85.70% of the company’s stock.
In related news, insider Christine Houston sold 19,889 shares of Express Scripts stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total value of $1,525,287.41. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.79% of the company’s stock.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Wednesday, May 2nd. The company reported $1.77 earnings per share for the quarter, beating analysts’ consensus estimates of $1.76 by $0.01. Express Scripts had a net margin of 4.59% and a return on equity of 25.41%. The firm had revenue of $24.77 billion for the quarter, compared to analyst estimates of $24.80 billion. During the same period last year, the firm posted $1.33 EPS. Express Scripts’s quarterly revenue was up .5% on a year-over-year basis. analysts forecast that Express Scripts Holding Co will post 9.07 earnings per share for the current fiscal year.
A number of brokerages have recently issued reports on ESRX. Barclays lowered their target price on shares of Express Scripts from $84.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 3rd. BidaskClub upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a research report on Wednesday. Jefferies Financial Group set a $91.00 target price on shares of Express Scripts and gave the stock a “buy” rating in a research report on Wednesday, February 28th. William Blair lowered shares of Express Scripts from an “outperform” rating to a “market perform” rating in a research report on Thursday, March 8th. Finally, ValuEngine lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a research report on Monday, April 2nd. Four investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $82.46.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.